NCT03273686

Efficacy of Nasogastric Tube Application in Postoperative Care of Esophagectomy

Status unknown Phase 3 Last updated 6 September 2017

What this trial tests

Phase 3 trial testing Discharge the NG tube during the surgery in Esophageal Cancer in 100 participants. Status unknown.

Timeline

15 September 2017

Primary endpoint
15 January 2018

15 April 2018

Quick facts

Lead sponsor	Fudan University
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	15 September 2017
Primary completion	15 January 2018
Estimated completion	15 April 2018

Drugs / interventions tested

• Discharge the NG tube during the surgery

Conditions studied

• Esophageal Cancer — all drugs for Esophageal Cancer →

Sponsor

Fudan University

Who can join

Adults 18 to 80, any sex, with Esophageal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nasogastric decompression is standard practice after esophageal resection in most centers because it is expected to reduce the incidence of esophagogastric anastomotic leakage by preventing overdistension of the gastric conduit. Most esophageal surgeons have been reluctant to move away from this tradition because of the considerable morbidity of anastomotic leaks after esophagectomy. However, a contrarian view is that the use of prolonged NGD may increase the incidence of postoperative pulmonary complications by promoting aspiration. Considering the numerous complications caused by using the tube and the uncertainty about its usefulness and the scarcity of studies conducted on the subject, particularly in patients with esophageal cancer, the necessity of using the tube in these types of cases is investigated in the present study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.